Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Recurrence after limited lung resection for small early-stage adenocarcinoma is three times more likely when the micropapillary component of the tumor is 5%…
NEW YORK (Reuters Health) – The addition of aprepitant to anti-emesis treatment seems to reduce the occurrence of nausea and vomiting among patients who are likely to experience…
NEW YORK (Reuters Health) – An increase in clonal complexity precedes the transformation of smoldering myeloma to malignant multiple myeloma, researchers have shown. “As such,” they infer, “the…
NEW YORK (Reuters Health) – A score based on four factors – low albumin, high bilirubin and α-fetoprotein, and large tumor size – is closely associated with mortality…
NEW YORK (Reuters Health) – In a phase III, multinational study of patients with heavily pretreated metastatic breast cancer, adding sunitinib to capecitabine provided no benefit, and in…
NEW YORK (Reuters Health) – The results of a phase III Italian study indicate that the risk of breast cancer in postmenopausal women who use hormone replacement therapy…
By Genevra Pittman NEW YORK (Reuters Health) – Men treated for prostate cancer with androgen deprivation therapy have a higher risk of developing kidney problems, a new study…
NEW YORK (Reuters Health) – Chemotherapy given in conjunction with regional hyperthermia produces good response rates in children and adolescents with refractory or recurrent germ-cell tumors, German researchers…
NEW YORK (Reuters Health) – When the cell adhesion molecule L1CAM is expressed in early-stage endometrial tumors, there is a 50% chance of recurrence, a multicenter study has…
NEW YORK (Reuters Health) – Men with azoospermia have a risk of developing cancer 2.9 times higher than the general population, according to data from a Texas andrology…
